Aspiriant LLC’s Vanguard Intermediate-Term Treasury ETF VGIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$764K Buy
12,829
+1,677
+15% +$100K 0.02% 178
2025
Q4
$668K Sell
11,152
-2,239
-17% -$135K 0.02% 191
2025
Q3
$804K Buy
13,391
+6,484
+94% +$387K 0.02% 165
2025
Q2
$413K Sell
6,907
-2,149
-24% -$127K 0.01% 217
2025
Q1
$538K Buy
9,056
+2,484
+38% +$145K 0.02% 184
2024
Q4
$381K Buy
+6,572
New +$386K 0.01% 213

Other funds holding VGIT

Aspiriant LLC's VGIT Position: Q1 2026 in Review

Aspiriant LLC increased its Vanguard Intermediate-Term Treasury ETF (VGIT) stake by 15% in Q1 2026, buying an estimated $100K and bringing the position to 12,829 shares worth $764K. The position accounts for 0.02% of the portfolio, ranked #178.

Aspiriant LLC first reported a position in VGIT in Q4 2024 and has held it in 6 quarters since. The position peaked at $804K in Q3 2025. 954 funds tracked by Wall St. Rank hold VGIT as of Q1 2026.

  • Aspiriant LLC held 12,829 shares of Vanguard Intermediate-Term Treasury ETF worth $764K as of Q1 2026.
  • Aspiriant LLC bought 1,677 Vanguard Intermediate-Term Treasury ETF shares in Q1 2026, an estimated $100K.
  • Vanguard Intermediate-Term Treasury ETF made up 0.02% of Aspiriant LLC's portfolio in Q1 2026, its #178 holding.
  • Aspiriant LLC first reported a position in Vanguard Intermediate-Term Treasury ETF in Q4 2024 and has held it in 6 quarters since.
  • Aspiriant LLC's Vanguard Intermediate-Term Treasury ETF position peaked at $804K in Q3 2025.
  • 954 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Treasury ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.